Cargando…
Aspirin‐targeted PD‐L1 in lung cancer growth inhibition
BACKGROUND: Aspirin is a classic anti‐inflammatory drug and its anticancer effect has been previously explored in many types of cancer including colorectal cancer therapy. Programmed cell death‐ligand 1 (PD‐L1) is widely expressed in tumor cells and displays an inhibitory role in antitumor immunity....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262895/ https://www.ncbi.nlm.nih.gov/pubmed/32297484 http://dx.doi.org/10.1111/1759-7714.13433 |